5-iminodaunorubicin has been researched along with Experimental Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glazer, RI; Hartman, KD; Richardson, CL | 1 |
| Acton, EM; Henry, DW; Tong, GL | 1 |
| Acton, EM | 1 |
1 review(s) available for 5-iminodaunorubicin and Experimental Neoplasms
| Article | Year |
|---|---|
Anthracycline mechanisms in analogue selection.
Topics: Animals; Daunorubicin; Doxorubicin; Drug Evaluation, Preclinical; Humans; Neoplasms, Experimental; Structure-Activity Relationship | 1985 |
2 other study(ies) available for 5-iminodaunorubicin and Experimental Neoplasms
| Article | Year |
|---|---|
Cytokinetic and biochemical effects of 5-iminodaunorubicin in human colon carcinoma in culture.
Topics: Cell Survival; Cells, Cultured; Colonic Neoplasms; Daunorubicin; DNA, Neoplasm; Doxorubicin; Humans; Molecular Weight; Neoplasms, Experimental; RNA, Neoplasm | 1982 |
5-Iminodaunorubicin. Reduced cardiotoxic properties in an antitumor anthracycline.
Topics: Animals; Daunorubicin; DNA; DNA, Neoplasm; Heart Diseases; Leukemia L1210; Mice; Mutagens; Neoplasm Transplantation; Neoplasms, Experimental; Rats; RNA, Neoplasm | 1979 |